Properties |
Information |
PhytoCAT-ID |
PhytoCAT-1317 |
Phytochemical name or plant extracts |
Phaleria macrocarpa extract (PMEAF) |
PMID |
28263848 |
Literature evidence |
Phaleria macrocarpa (Boerl.) fruit induce G(0)/G(1) and G(2)/M cell cycle arrest and apoptosis through mitochondria-mediated pathway in MDA-MB-231 human breast cancer cell. |
IUPAC name |
NA |
Phytochemicals’ class or type of plant extracts |
Ethyl acetate fraction |
Source of phytochemicals or plant Extracts |
Phaleria macrocarpa |
|
Geographical availability |
New Guinea |
Plant parts |
Fruits |
Other cancers |
Breast cancer |
Target gene or protein |
Bax, Bid, Caspase 3, Caspase 8, cyt-c, p21, p27, p53, SMAC, Bcl-2, Bcl-w, XIAP, Survivin |
Gene or Protein evidence |
The results from apoptosis protein profiling array evidenced that PMEAF stimulated the expression of 9 pro-apoptotic proteins (Bax, Bid, caspase 3, caspase 8, cytochrome c, p21, p27, p53 and SMAC) and suppressed the 4 anti-apoptotic proteins (Bcl-2, Bcl-w, XIAP and survivin) in MDA-MB-231 cells. |
Target pathways |
The results indicated that PMEAF treatment induced apoptosis in MDA-MB-231 cells through intrinsic mitochondrial related pathway with the participation of pro and anti-apoptotic proteins, caspases, G0/G1 and G2/M-phases cell cycle arrest by p53-mediated mechanism. |
IC50 |
18.10 µg/mL against MDA-MB-231 |
Potency |
Both results were indicated that the PMEAF is a potential anticancer agent with the average IC50 values of 18.10µg/mL by inhibiting the MDA-MB-231 cell proliferation. |
Cell line/ mice model |
MDA-MB-231 |
Additional information |
Moreover, the PMEAF exert cytotoxicity by increased the ROS production in MDA-MB-231 cells consistently stimulated the loss of mitochondrial membrane potential (∆Ψm) and induced apoptosis cell death by activation of numerous signalling proteins. |
PubChem ID |
NA |
Additional PMIDs |
20734918 20703095 24818141 24885709 |
Additional sources of information |
https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:832478-1 |
Safety |
NA |